KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash from Financing Activities (2016 - 2025)

Globus Medical's Cash from Financing Activities history spans 15 years, with the latest figure at $13.2 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 77.88% year-over-year to $13.2 million; the TTM value through Dec 2025 reached -$679.2 million, down 2352.2%, while the annual FY2025 figure was -$679.2 million, 2352.2% down from the prior year.
  • Cash from Financing Activities reached $13.2 million in Q4 2025 per GMED's latest filing, up from -$32.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $59.7 million in Q4 2024 to a low of -$635.4 million in Q1 2025.
  • Average Cash from Financing Activities over 5 years is -$49.7 million, with a median of $4.5 million recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 1428.54% in 2022, then plummeted 4036.09% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.0 million in 2021, then surged by 1428.54% to $13.6 million in 2022, then crashed by 1845.79% to -$237.3 million in 2023, then skyrocketed by 125.18% to $59.7 million in 2024, then plummeted by 77.88% to $13.2 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Cash from Financing Activities are $13.2 million (Q4 2025), -$32.0 million (Q3 2025), and -$24.9 million (Q2 2025).